| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H Gur, I Mendel, N Kerlero de Rosbo, A Ben-Nu. Effect of the bm12 class II mutation on proliferative and cytokine responses of encephalitogenic T cells in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis. Journal of autoimmunity. vol 13. issue 1. 1999-11-04. PMID:10441162. |
we have studied the effect of this mutation on experimental autoimmune encephalomyelitis (eae), induced in h-2(b)mice by myelin oligodendrocyte glycoprotein (mog), and recently showed that mog 35-55 peptide (pmog 35-55), which represents the immunodominant encephalitogenic region for h-2(b)mice, is also a strong encephalitogen for h-2(bm12)mice. |
1999-11-04 |
2023-08-12 |
mouse |
| T T Chang, C Jabs, R A Sobel, V K Kuchroo, A H Sharp. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. The Journal of experimental medicine. vol 190. issue 5. 1999-10-14. PMID:10477557. |
in this study, the role of b7-cd28 costimulation and the relative importance of b7 costimulators for the induction and effector phases of experimental autoimmune encephalomyelitis (eae) induced by myelin oligodendrocyte glycoprotein (mog) peptide were examined. |
1999-10-14 |
2023-08-12 |
mouse |
| R Furlan, G Martino, F Galbiati, P L Poliani, S Smiroldo, A Bergami, G Desina, G Comi, R Flavell, M S Su, L Adorin. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. Journal of immunology (Baltimore, Md. : 1950). vol 163. issue 5. 1999-09-14. PMID:10452974. |
a reduction of eae incidence and severity is observed in caspase-1-deficient mice, depending on the immunogenicity and on the amount of the encephalitogenic myelin oligodendrocyte glycoprotein (mog) peptide used. |
1999-09-14 |
2023-08-12 |
mouse |
| D R Goddard, M Berry, A M But. In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. Journal of neuroscience research. vol 57. issue 1. 1999-08-04. PMID:10397637. |
in parallel experiments, amv were treated for western blot analysis to determine relative changes in expression of the myelin proteins 2', 3'-cyclic nucleotide 3'-phosphohydrolase (cnp) and myelin oligodendrocyte glycoprotein (mog), which, respectively, characterise early and late stages of myelin maturation. |
1999-08-04 |
2023-08-12 |
rat |
| A Stefferl, U Brehm, M Storch, D Lambracht-Washington, C Bourquin, K Wonigeit, H Lassmann, C Liningto. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. Journal of immunology (Baltimore, Md. : 1950). vol 163. issue 1. 1999-07-15. PMID:10384097. |
experimental autoimmune encephalomyelitis (eae) induced by active immunization with the myelin oligodendrocyte glycoprotein (mog) is an ab-mediated, t cell-dependent autoimmune disease that replicates the inflammatory demyelinating pathology of multiple sclerosis. |
1999-07-15 |
2023-08-12 |
rat |
| U Brehm, S J Piddlesden, M V Gardinier, C Liningto. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). Journal of neuroimmunology. vol 97. issue 1-2. 1999-07-12. PMID:10408984. |
epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (mog). |
1999-07-12 |
2023-08-12 |
human |
| V Jaquet, G Pfend, M Tosic, J M Matthie. Analysis of cis-acting sequences from the myelin oligodendrocyte glycoprotein promoter. Journal of neurochemistry. vol 73. issue 1. 1999-07-08. PMID:10386962. |
myelin oligodendrocyte glycoprotein (mog), a minor component of the myelin sheath, appears to be implicated in the late events of cns myelinogenesis. |
1999-07-08 |
2023-08-12 |
mouse |
| F Mokhtarian, Z Zhang, Y Shi, E Gonzales, R A Sobe. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. Journal of neuroimmunology. vol 95. issue 1-2. 1999-05-17. PMID:10229114. |
to investigate the role of molecular mimicry in the pathogenesis of postviral demyelination, alignment algorithms were used and amino acid homologies between immunogenic epitopes of sfv and myelin autoantigens, myelin basic protein (mbp), myelin proteolipid protein (plp) and myelin oligodendrocyte glycoprotein (mog) were identified. |
1999-05-17 |
2023-08-12 |
mouse |
| S Weerth, T Berger, H Lassmann, C Liningto. Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat. Journal of neuroimmunology. vol 95. issue 1-2. 1999-05-17. PMID:10229126. |
co-transfer of mp1.1 (a.a. sequence 20-34)-specific t cells with the myelin oligodendrocyte glycoprotein (mog)-specific monoclonal antibody 8-18c5 enhanced disease severity and induced widespread demyelination in the cns. |
1999-05-17 |
2023-08-12 |
rat |
| A Karni, R Bakimer-Kleiner, O Abramsky, A Ben-Nu. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Archives of neurology. vol 56. issue 3. 1999-04-14. PMID:10190821. |
to evaluate the presence and specificity of anti-myelin oligodendrocyte glycoprotein (mog) antibody in the cerebrospinal fluid and plasma of patients with multiple sclerosis (ms). |
1999-04-14 |
2023-08-12 |
Not clear |
| H I McFarland, A A Lobito, M M Johnson, J T Nyswaner, J A Frank, G R Palardy, N Tresser, C P Genain, J P Mueller, L A Matis, M J Lenard. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis. Journal of immunology (Baltimore, Md. : 1950). vol 162. issue 4. 1999-04-13. PMID:9973519. |
demyelination was associated with spreading to myelin oligodendrocyte glycoprotein (mog) determinants that generated anti-mog serum abs and ig deposition in central nervous system white matter lesions. |
1999-04-13 |
2023-08-12 |
marmoset |
| H P Eugster, K Frei, R Bachmann, H Bluethmann, H Lassmann, A Fontan. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. European journal of immunology. vol 29. issue 2. 1999-03-16. PMID:10064079. |
in wild-type (wt) mice immunized with myelin oligodendrocyte glycoprotein (mog) peptide 35-55 the clinical course is characterized by an acute disease onset with peak disease scores and a consecutive chronic phase lasting up to 60 days. |
1999-03-16 |
2023-08-12 |
mouse |
| M Ichikawa, C S Koh, Y Inaba, C Seki, A Inoue, M Itoh, Y Ishihara, C C Bernard, A Komiyam. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cellular immunology. vol 191. issue 2. 1999-03-15. PMID:9973531. |
we have recently shown that a single dose of the myelin oligodendrocyte glycoprotein (mog) peptide 35-55 produces a relapsing-remitting demyelinating disease similar to multiple sclerosis (ms) in lewis rats. |
1999-03-15 |
2023-08-12 |
mouse |
| M K Storch, A Stefferl, U Brehm, R Weissert, E Wallström, M Kerschensteiner, T Olsson, C Linington, H Lassman. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain pathology (Zurich, Switzerland). vol 8. issue 4. 1999-01-29. PMID:9804377. |
recently, however, a new model of myelin oligodendrocyte glycoprotein (mog) induced autoimmune encephalomyelitis became available, which, in a very standardized and predictable way, leads to chronic (relapsing or progressive) disease and widespread cns demyelination. |
1999-01-29 |
2023-08-12 |
rat |
| B della Gaspera, D Pham-Dinh, G Roussel, J L Nussbaum, A Dautign. Membrane topology of the myelin/oligodendrocyte glycoprotein. European journal of biochemistry. vol 258. issue 2. 1999-01-28. PMID:9874214. |
myelin/oligodendrocyte glycoprotein (mog), a specific component of the mammalian central nervous system, is located on the surface of the oligodendrocyte plasma membrane and the outermost lamellae of mature myelin; it is expressed during the latter steps of myelinogenesis. |
1999-01-28 |
2023-08-12 |
Not clear |
| E B Samoilova, J L Horton, B Hilliard, T S Liu, Y Che. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. Journal of immunology (Baltimore, Md. : 1950). vol 161. issue 12. 1999-01-22. PMID:9862671. |
we found that il-6-deficient mice were completely resistant to eae induced by myelin oligodendrocyte glycoprotein (mog), whereas il-6-competent control mice developed eae characterized by focal inflammation and demyelination in the central nervous system and deficiency in neurologic functions. |
1999-01-22 |
2023-08-12 |
mouse |
| T G Johns, C C Bernar. The structure and function of myelin oligodendrocyte glycoprotein. Journal of neurochemistry. vol 72. issue 1. 1999-01-21. PMID:9886048. |
myelin oligodendrocyte glycoprotein (mog) is a quantitatively minor component of cns myelin whose function remains relatively unknown. |
1999-01-21 |
2023-08-12 |
mouse |
| T G Johns, C C Bernar. The structure and function of myelin oligodendrocyte glycoprotein. Journal of neurochemistry. vol 72. issue 1. 1999-01-21. PMID:9886048. |
on the basis of this knowledge we suggest three possible functions for mog: (a) a cellular adhesive molecule, (b) a regulator of oligodendrocyte microtubule stability, and (c) a mediator of interactions between myelin and the immune system, in particular, the complement cascade. |
1999-01-21 |
2023-08-12 |
mouse |
| M N Grote, W Klitz, G Thomso. Constrained disequilibrium values and hitchhiking in a three-locus system. Genetics. vol 150. issue 3. 1999-01-07. PMID:9799280. |
we present a microsatellite data set from human chromosome 6, in which constrained disequilibrium values suggest the action of selection in a region containing the human leukocyte antigen (hla)-a and myelin oligodendrocyte glycoprotein (mog) loci. |
1999-01-07 |
2023-08-12 |
human |
| A Slavin, C Ewing, J Liu, M Ichikawa, J Slavin, C C Bernar. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity. vol 28. issue 2. 1998-12-29. PMID:9771980. |
myelin oligodendrocyte glycoprotein (mog) is postulated to be a target autoantigen in multiple sclerosis (ms). |
1998-12-29 |
2023-08-12 |
mouse |